Paper of the Year

For the meeting in 2019, the award for the best paper published the previous year was 1,000 €.

Nomination process:

1.

A senior scientist can nominate a first author of a paper published in print or online in the year before the meeting (2019).

2.

The first author should have max 3 years of experience since completion of PhD, when the paper is published in print or online.

3.

The first author or the research group should regularly have been participating in the SSAR meetings.

4.

The first author should attend the meeting and the galla dinner to recieve the award.

The nomination must be sent by email (the deadline will be annnounced soon) to:

Kirsten B. Holven, Department of Nutrition University of Oslo, Sognsvannsveien 9 Domus Medica 0372 Oslo

E-mail: k.b.holven@medisin.uio.no

Please, remember to write “Paper award” in the subject of your email!

The nomination email must include:

1.

A brief statement from the senior author that the first author contributed substantially to the work.

2.

Affiliation and email addresses of first and senior authors.

3.

The publication attached as a pdf file.

The nominations will be evaluated by the scientific chairpersons (organizing committee), and the winner will be announced at the galla dinner at the 31st Annual Scandinavian Atherosclerosis Conference, 2-5 April 2025, in Humlebæk, Denmark.

Year
Winner
Paper
2024

Jiao Luo
University of Copenhageny, Denmark

Jiao Luo et al: INeutrophil counts and cardiovascular disease Eur Heart J . 2023 Dec 14;44(47):4953-4964.

2023

Pieter Goosens
Maastricht University, The Netherlands

Pieter Goonsens et al: Integrating multiplex immunofluorescent and mass spectrometry imaging to map myeloid heterogeneity in its metabolic and cellular context Cell Metab . 2022 Aug 2;34(8):1214-1225.e6.

2022

Camilla Ditlev Lindhardt Johannesen
Copenhagen University Hospital, Denmark;

Camilla Ditlev Lindhardt Johannesen et al: Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients J Am Coll Cardiol . 2021 Mar 23;77(11):1439-1450

2021

Ida Juul Rasmussen
Rigshospitalet, Denmark;

Juul Rasmussen I et al: Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention. Eur Heart J. 2020 Nov 1;41(41):4024-4033

2020

Maaike Schilperoort
Leiden University Medical Center, Leiden, The Netherlands;

Schilperoort M et al: Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice.    J Pineal Res. 2020 Jan;68(1):e12614

2019

Maija Ruuth
WihuriResearch Institute, Helsinki, Finland;

Ruuth M et al: Susceptibility of LDL particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths. Eur Heart J. 2018; 39:2562–2573

2018

Christian Medom Madsen
Herlev Hospital, Copenhagen, Denmark

Madsen CM et al: Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J. 2017 Aug 21;38(32):2478-2486.

2017

Emiel van der Vorst and Kosta Theodorou
Maastricht University, The Netherlands.

van der Vorst EPC, Theodorou K et al: High Density Lipoproteins exert proinflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kB/STAT1-IRF-1 signaling Cell Metab. 2017 Jan 10;25(1):197-207

2016

Jimmy Berbée & Mariëtte Boon Leiden University Medical Center, The Netherlands.

Berbée & Boon et al: Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nature Communications 2015; 6: 6356

2015

Anders
Berg Jørgensen
,
Rigshospitalet, Denmark

Anders Berg Jørgensen, Ruth Frikke-Schmidt, Børge G. Nordestgaard, and Anne Tybjærg-Hansen. Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
N Engl J Med 2014; 371:32-41.

2014

Mette Christoffersen ,
Rigshospitalet, Denmark

Mette Christoffersen, Ruth Frikke-Schmidt, Peter Schnohr, Gorm B. Jensen, Børge G. Nordestgaard and Anne Tybjaerg-Hansen. Visible Age-Related Signs and Risk of Ischemic Heart Disease in the General Population: A Prospective Cohort Study
Circulation. 2014 Mar 4;129(9):990-8.

2013

Reija Silvennoinen,
Wihuri Research Institute, Finland

Silvennoinen R, Escola-Gil JC, Julve J, Rotllan N, Llaverias G, Metso J, Valledor AF, He J, Yu L, Jauhiainen M, Blanco-Vaca F, Kovanen PT, Lee-Rueckert M. Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption.
Circ Res. 2012;111:1459-1469.

2012

Christina Christoffersen,
Rigshospitalet, Denmark

Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnström J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlbäck B. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Proc Natl Acad Sci U S A. 2011;108(23):9613-8.

2011

Mette K. Hagensen,
Aarhus University Hospital, Denmark

Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis.
Circulation. 2010;121(7):898-905

2010

Pia Kamstrup ,
Herlev University Hospital, Denmark

Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
JAMA. 2009; 301(22):2331-9.

2009

Jeppe Zacho,
Herlev University Hospital, Denmark

Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease.
N Engl J Med. 2008 30;359(18):1897-908.

2008

Ilze Bot,
Leiden University, The Netherlands.

Bot I, de Jager SCA, Zernecke A, Lindstedt KA, van Berkel TJC, Weber C, Biessen EAL. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice.
Circulation 2007;115:2516-2525